LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding

Links shared publicly online about this topic.

  • 961
    total visits

LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding

medicalnewstoday.com

For an estimated 22 million women in America, monthly menstrual periods are so heavy they can sap energy, cause anemia, and interfere with daily activities. These sufferers of cyclic heavy menstr

View full resource at medicalnewstoday.com

Tags: Anemia, Bleeding, Menstruation, Women's Health

  • Share

Most Recently Shared on August 9, 2010 at 12:19 pm By:

mnt_womenhealth MNT Women's Health

LYSTEDA Available For Women With Cyclic Heavy Menstrual Bleeding http://mnt.to/3H6K #womenshealth

2 years ago...

Also Shared By:

Women's Health Line Women's Health Line

MNT Health News MNT Health News

Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health Blog

drpullen.com — “Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health BlogView full resource at drpullen.com

  • View Related
  • Share

Most Recently Shared on July 29, 2011 at 1:45 pm By:

DrEdPullen Ed Pullen Physician, Active Health Library, Doctor, and Family Medicine Doctor

Lysteda for the Management of Heavy Menstrual Bleeding | DrPullen.com – Medical and Health Blog http://fb.me/Ucuo3ECv

9 months ago...

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

news-medical.net — “Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 9:25 am By:

Stroke_News News-Medical.Net Health News

Stroke News: Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB: Ferring... http://twurl.nl/vvakzl

2 years ago...

Lysteda available for heavy menstrual bleeding - MPR

empr.com — “Ferring Pharmaceuticals has launched Lysteda (tranexamic acid tablets) for the treatment of cyclic heavy menstrual bleeding (HMB) in women.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 21, 2010 at 2:37 pm By:

eMPR MPR Medical Publisher

MPR News: Lysteda available for heavy menstrual bleeding: Ferring Pharmaceuticals has launched Lysteda (tranexamic... http://bit.ly/9tlIex

2 years ago...

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

news-medical.net — “Ferring Pharmaceuticals today announced an agreement that will expand its Women's Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical's LYSTEDA" (tranexamic acid), a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding (HMB).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 10, 2010 at 3:00 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA: Ferring Pharmaceuticals toda... http://twurl.nl/ozmlnd

2 years ago...

FDA approves Lysteda for treating menorrhagia

news-medical.net — “Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 5:24 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA approves Lysteda for treating menorrhagia: Xanodyne Pharmaceuticals, Inc., an inte.. http://twurl.nl/njohb3

2 years ago...

Lysteda approved for heavy menstrual bleeding - MPR

empr.com — “The FDA has approved Lysteda (tranexamic acid tablets, from Xanodyne), a non-hormonal treatment for women suffering from menorrhaghia, cyclic heavy menstrual bleeding (HMB).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on November 16, 2009 at 4:27 pm By:

eMPR MPR Medical Publisher

MPR News: Lysteda approved for heavy menstrual bleeding: The FDA has approved Lysteda (tranexamic acid tablets, fro... http://bit.ly/3Mf1Lm

2 years ago...

Advertisement